연구성과로 돌아가기

2024 연구자 정보 (37 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, E.
(Kim, E)
Kyungpook Natl Univ Hosp, Daegu, South Korea

[JCR상위 1.5] Performance evaluation of the automated cell image analyzer DI-60 for leukocyte differential count SCIE 1.5 MEDICAL LABORATORY TECHNOLOGY
Kim, Hee-je
(Kim, HJ)
Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Seoul, South Korea

[JCR상위 1.5] Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy? SCIE 1.5 HEMATOLOGY
Kim, Hee-Je
(Kim, HJ)
Catholic Univ Korea, Seoul St Marys Hematol Hosp, Seoul, South Korea

[JCR상위 1.5] The 66th ASH Annual Meeting Abstracts ORAL ABSTRACTS SCIE 1.5 HEMATOLOGY
Kim, Hyeoung-Joon
(Kim, HJ)
Chonnam Natl Univ, Hwasun Hosp, Hwasun, South Korea
Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Dept Hematol Oncol, Med Sch, Gwangju, Jeollanam Do, South Korea
Chonnam Natl Univ, Hwasun Hosp, Genom Res Ctr Hematopoiet Dis, Gwangju, Jeollanam Do, South Korea


[JCR상위 1.5] The 66th ASH Annual Meeting Abstracts ORAL ABSTRACTS
[JCR상위 18.1] Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia
[JCR상위 1.5] Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?
SCIE 1.5 HEMATOLOGY
MULTIDISCIPLINARY SCIENCES
f0115@chonnam.ac.kr;dr.dennis.kim@uhn.ca;
Kim, Hyung-Kwan
(Kim, HK)
Seoul Natl Univ Hosp, Div Cardiol, Seoul, South Korea ITU-6159-2023
Kim, Hyung-Kwan

[JCR상위 1.5] Effect of Evogliptin on the Progression of Aortic Valvular Calcification SCIE 1.5 CARDIAC & CARDIOVASCULAR SYSTEMS jksong@amc.seoul.kr;
Kim, J. I. Yoon
(Kim, JY)
Kyungpook Natl Univ, Sch Med, Dept Pediat, Daegu, South Korea

[JCR상위 1.5] Completion of the First Phase of Registration: Baseline Characteristics and Epidemiology of Hemophilia in Korea from the Korean Bleeding Disorder Registry (KBDR) SCIE 1.5 HEMATOLOGY
Kim, Sang-Jae
(Kim, SJ)
교신저자 Jeju Natl Univ, Fac Appl Energy Syst, Nanomat & Syst Lab, Major Mechatron Engn, Jeju 63243, South Korea
Jeju Natl Univ, Coll Engn, Nanomat & Syst Lab, Major Mech Syst Engn, Jeju 63243, South Korea
Jeju Natl Univ, Res Inst New Energy Ind RINEI, Jeju 63243, South Korea
Jeju Natl Univ, Green Hydrogen Glocal Leading Res Ctr gH2 RC, Jeju 63243, South Korea
S-4053-2019
Kim, Sang-Jae

[JCR상위 1.5] Augmented neuromuscular transmission: bridging physical and cognitive practices through intrinsic hybrid nanogenerator-integrated confirmation analysis system SCIE 1.5 MATERIALS SCIENCE, COMPOSITES;NANOSCIENCE & NANOTECHNOLOGY sathyaprabakaran.94@gmail.com;monunith.a@gmail.com;alluri@knu.ac.kr;kimsangj@jejunu.ac.kr;
Kim, Soon Ki
(Kim, SK)
Inha Univ, Dept Pediat, Incheon, South Korea

[JCR상위 1.5] Completion of the First Phase of Registration: Baseline Characteristics and Epidemiology of Hemophilia in Korea from the Korean Bleeding Disorder Registry (KBDR) SCIE 1.5 HEMATOLOGY
Kim, Y.
(Kim, Y)
Inst for Basic Sci Korea, Rare Isotope Sci Project, Daejeon 34000, South Korea
Kyungpook Natl Univ Hosp, Daegu, South Korea
Kyungpook Natl Univ, Dept Math, Daegu 41566, South Korea
Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
Janssen Korea Ltd, Med Affairs, Seoul, South Korea
Chungbuk Natl Univ, Chungbuk Natl Univ Observ, Cheongju 28644, South Korea


Preparations of QWR superconducting cavities for beam commissioning
[JCR상위 1.5] Performance evaluation of the automated cell image analyzer DI-60 for leukocyte differential count
[JCR상위 1.0] THE IMPORTANCE OF PROVEN TREATMENT AS A VACCINE MODEL FOR COVID-19
[JCR상위 1.1] Tumor-immune spatial interactions on NSCLC H&E slide images predicts immunotherapy response: Preliminary external validation
[JCR상위 75.3] Performance of the prototype beam drift chamber for LAMPS at RAON with proton and 12C beams
[JCR상위 2.3] Semi-Automated NSCLC Segmentation and RECIST Measurement: Bridging the Gap Between Speed and Radiologist-Level Accuracy
[JCR상위 7.8] One-year safety and effectiveness of ustekinumab in patients with Crohn's disease: The K-STAR study
[JCR상위 18.5] Absolute dimensions of solar-type eclipsing binaries
SCIE 1.0 MEDICAL LABORATORY TECHNOLOGY
MATHEMATICS, APPLIED
ONCOLOGY
INSTRUMENTS & INSTRUMENTATION
ONCOLOGY;RESPIRATORY SYSTEM
GASTROENTEROLOGY & HEPATOLOGY
ASTRONOMY & ASTROPHYSICS
kimht7@ibs.re.kr;
sangil.kim@pusan.ac.kr;
dhmoon@chonnam.ac.kr;
tchinse@gmail.com;
Kim, Yundeok
(Kim, Y)
Wonju Severance Christian Hosp, Wonju, South Korea

[JCR상위 1.5] Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment SCIE 1.5 HEMATOLOGY
Kwon, Seung Yeon
(Kwon, SY)
Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Dept Pediat, Seoul, South Korea

[JCR상위 1.5] Completion of the First Phase of Registration: Baseline Characteristics and Epidemiology of Hemophilia in Korea from the Korean Bleeding Disorder Registry (KBDR) SCIE 1.5 HEMATOLOGY
Lee, Gyeong Won
(Lee, GW)
Gyeongsang Natl Univ, Coll Med, Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea
Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju 52727, South Korea


[JCR상위 1.5] Predicting Molecular Response through Half Reduction of Neutrophil-to-Lymphocyte Ratio (NLR) in Polycythemia Vera Treatment with Ropeginterferon
[JCR상위 1.5] Refining Symptom Response Criteria in Polycythemia Vera Patients Treated with Ropeginterferon Alfa-2b
[JCR상위 1.5] Distinct Factors Influence on Complete Hematological Response Maintenance in Polycythemia Vera Patients Treated with Alfa-2b: From a Phase 2 in South Korea
SCIE 1.5 HEMATOLOGY
Lee, Haewon
(Lee, HW)
Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Dept Pediat, Seoul, South Korea

[JCR상위 1.5] Completion of the First Phase of Registration: Baseline Characteristics and Epidemiology of Hemophilia in Korea from the Korean Bleeding Disorder Registry (KBDR) SCIE 1.5 HEMATOLOGY
Lee, Hee jeong
(Lee, HJ)
Chosun Univ Hosp, Dept Internal Med Hemato Oncol, Gwangju, South Korea

[JCR상위 1.5] Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment SCIE 1.5 HEMATOLOGY
Lee, Jae Hoon
(Lee, JH)
Gachon Univ, Gil Med Ctr, Incheon, South Korea
Gachon Univ, Gil Med Ctr, Coll Med, Div Hematol, Incheon, South Korea


[JCR상위 1.5] Prognostic Impact of Response Kinetics and Influencing Factors in Multiple Myeloma Patients Treated with Carfilzomib- or Ixazomib-Based Treatment
[JCR상위 10.7] Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study
SCIE 1.5 HEMATOLOGY kshmoon@dau.ac.kr;kihyunkimk@gmail.com;
페이지 이동: